Sepsis and Septic Shock Treatment Market

Sepsis is usually treated with intravenous fluids and antibiotics. Typically, antibiotics are given as soon as possible. Often, ongoing care is performed in an intensive care unit. If fluid replacement is not enough to maintain blood pressure, medications that raise blood pressure may be used. Mechanical ventilation and dialysis may be needed to support the function of the lungs and kidneys, respectively. To guide treatment, a central venous catheter and an arterial catheter may be placed for access to the bloodstream. Other measurements such as cardiac output and superior vena cava oxygen saturation may be used. People with sepsis need preventive measures for deep vein thrombosis, stress ulcers and pressure ulcers, unless other conditions prevent such interventions. Some might benefit from tight control of blood sugar levels with insulin. The use of corticosteroids is controversial, with some reviews finding benefit, and others not.
Sepsis and Septic Shock Treatment Market contains market size and forecasts of Sepsis and Septic Shock Treatment in Global, including the following market information:
Global Sepsis and Septic Shock Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Sepsis and Septic Shock Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Cephalosporin Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Sepsis and Septic Shock Treatment include Pfizer, NCPC, Bayer, Shanghai Pharmaceuticals, Johnson & Johnson, Novartis, GlaxoSmithKline, TEVA and Mylan, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Sepsis and Septic Shock Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Sepsis and Septic Shock Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Sepsis and Septic Shock Treatment Market Segment Percentages, by Type, 2021 (%)
Cephalosporin
Pencillin
Macrolides
Others
Global Sepsis and Septic Shock Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Sepsis and Septic Shock Treatment Market Segment Percentages, by Application, 2021 (%)
Sepsis
Septic Shock
Global Sepsis and Septic Shock Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Sepsis and Septic Shock Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Sepsis and Septic Shock Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Sepsis and Septic Shock Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
NCPC
Bayer
Shanghai Pharmaceuticals
Johnson & Johnson
Novartis
GlaxoSmithKline
TEVA
Mylan
AbbVie
Merck & Co
Asahi Kasei
AtoxBio
INOTREM
Adrenomed
Endacea